Evidence map›Paper›PMID 19763745›Full record

ArticleInternational journal of hematology2009

Sequential adenovirus infection of type 14 hemorrhagic cystitis and type 35 generalized infection after cord blood transplantation.

Takashi Abe, Tatsuo Furukawa, Masayoshi Masuko, Atsunori Sugimoto, Kiyoshi Okazuka, Keiichiro Honma, Takeo Fujimura, Seitaro Iguchi, Shinichi Nishi, Mitsuhiro Ueno and 7 more

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in International journal of hematology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
0.3field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 4 institutions in 1 country.

Takashi AbeDivision of Hematology, Department of Regenerative and Transplant Medicine, Niigata University Graduate School of Medicine and Dental Science, Asahimachi-dori 754, Niigata, 951-8510, Japan. abetaka@med.niigata-u.ac.jp.
Tatsuo FurukawaDivision of Bone Marrow Transplantation, Niigata University Medical and Dental Hospital, Niigata, Japan.
Masayoshi MasukoDivision of Bone Marrow Transplantation, Niigata University Medical and Dental Hospital, Niigata, Japan.
Atsunori SugimotoDivision of Hematology, Department of Regenerative and Transplant Medicine, Niigata University Graduate School of Medicine and Dental Science, Asahimachi-dori 754, Niigata, 951-8510, Japan.
Kiyoshi OkazukaDivision of Hematology, Department of Regenerative and Transplant Medicine, Niigata University Graduate School of Medicine and Dental Science, Asahimachi-dori 754, Niigata, 951-8510, Japan.
Keiichiro HonmaDivision of Hematology, Department of Regenerative and Transplant Medicine, Niigata University Graduate School of Medicine and Dental Science, Asahimachi-dori 754, Niigata, 951-8510, Japan.
Takeo FujimuraDivision of Clinical Nephrology and Rheumatology, Niigata University Graduate School of Medicine and Dental Science, Niigata, Japan.
Seitaro IguchiDivision of Clinical Nephrology and Rheumatology, Niigata University Graduate School of Medicine and Dental Science, Niigata, Japan.
Shinichi NishiDivision of Clinical Nephrology and Rheumatology, Niigata University Graduate School of Medicine and Dental Science, Niigata, Japan.
Mitsuhiro UenoDivision of Clinical Nephrology and Rheumatology, Niigata University Graduate School of Medicine and Dental Science, Niigata, Japan.
Masayuki NagahashiDivision of Molecular Diagnostic Pathology, Niigata University Medical and Dental Hospital, Niigata, Japan.
Gen WatanabeDivision of Molecular Diagnostic Pathology, Niigata University Medical and Dental Hospital, Niigata, Japan.
Yoichi AjiokaDivision of Molecular Diagnostic Pathology, Niigata University Medical and Dental Hospital, Niigata, Japan.
Noriatsu IsahaiNiigata Prefecture Central Hospital, Niigata, Japan.
Koichi NagaiNiigata Prefecture Central Hospital, Niigata, Japan.
Yukumasa KazuyamaKitazato-Otsuka Biomedical Assay Laboratories Co., LTD, Kanagawa, Japan.
Yosifusa AizawaDivision of Hematology, Department of Regenerative and Transplant Medicine, Niigata University Graduate School of Medicine and Dental Science, Asahimachi-dori 754, Niigata, 951-8510, Japan.
Niigata University · JPNiigata University Medical and Dental Hospital · JPNiigata Prefectural Central Hospital · JPOtsuka (Japan) · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We report a case of a 29-year-old male patient with a generalized adenovirus (AdV) infection after cord blood transplantation (CBT) for acute myelocytic leukemia with maturation at 2nd complete remission. Before engraftment, hemorrhagic cystitis was caused by AdV, which resulted in hydronephrosis, renal failure, and adenoviremia on day 34. Forced diuresis, hemodialysis, withdrawal of cyclosporin A, and administration of gamma-globulin or vidarabine were not effective and the patient died of pulmonary alveolar hemorrhage on day 67. At autopsy, old inflammatory change only was observed in the bladder section. In the lungs and kidneys, granular deposits in the nucleus and a high copy number of AdV-DNA were observed. Molecular diagnosis using PCR-restriction fragment length polymorphism analysis demonstrated that AdV with the serotype 14 caused the cystitis. However, retrospective genome typing using PCR sequencing revealed the infection of AdV serotype 35 in the kidneys, lungs, and serum. The present case suggested that Adv infection could not be always caused by a single AdV serotype, and suggested that multiple serotype infection was very difficult to treat. It is desired that a consensus regarding the treatment of AdV infections is established.

Indexed as

Adenovirus Infections, HumanAdultCord Blood Stem Cell TransplantationCystitisFatal OutcomeHemorrhageHumansLeukemia, Myeloid, AcuteMaleUrinary Bladder

Identifiers

PMID19763745
OpenAlexW2048803028

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.